Carpenter A J, Ylioja C M, Vargas C F, Mamedova L K, Mendonça L G, Coetzee J F, Hollis L C, Gehring R, Bradford B J
Department of Animal Sciences and Industry, Kansas State University, Manhattan 66506.
Department of Veterinary Diagnostic and Production Animal Medicine, Iowa State University, Ames 50011.
J Dairy Sci. 2016 Jan;99(1):672-9. doi: 10.3168/jds.2015-10048. Epub 2015 Oct 29.
Previous research has shown that postpartum administration of the nonsteroidal antiinflammatory drug (NSAID) sodium salicylate can increase 305-d milk yield in older dairy cattle (parity 3 and greater). However, in this prior work, sodium salicylate was delivered to cows via the drinking water, a method that does not align well with current grouping strategies on commercial dairy farms. The objective of the current study was to replicate these results on a commercial dairy farm with a simplified treatment protocol and to compare sodium salicylate with another NSAID, meloxicam. Dairy cattle in their second lactation and greater (n=51/treatment) were alternately assigned to 1 of 3 treatments at parturition, with treatments lasting for 3d. Experimental treatments began 12 to 36 h after parturition and were (1) 1 placebo bolus on the first day and 3 consecutive daily drenches of sodium salicylate (125 g/cow per day; SAL); (2) 1 bolus of meloxicam (675 mg/cow) and 3 drenches of an equal volume of water (MEL); or (3) 1 placebo bolus and 3 drenches of water (CON). Blood samples were collected on the first day of treatment, immediately following the last day of treatment, and 7d after the last day of treatment; plasma was analyzed for glucose, β-hydroxybutyrate (BHB), free fatty acids, haptoglobin, and paraoxonase. Milk production, body condition score, reproductive status, and retention in the herd were monitored for 365 d posttreatment, and effects of treatment, parity, days in milk, and interactions were evaluated in mixed effects models. Significance was declared at P<0.05. Whole-lactation milk and protein yields were greater in NSAID-treated cows, although 305-d fat production was not affected. There was a significant interaction of treatment and parity for plasma glucose concentration; MEL increased plasma glucose concentrations compared with CON and SAL in older cows. Sodium salicylate decreased plasma BHB concentration compared with MEL at 7d posttreatment, although no difference was detected immediately following treatment. Haptoglobin concentrations were elevated in SAL cows compared with CON. There was a tendency for CON cows to be removed from the herd more quickly than MEL cows (42 vs. 26% at 365 d posttreatment). Body condition score, concentrations of plasma free fatty acids and paraoxonase, and time to pregnancy were not affected by treatment. These results indicate that NSAID administration in postpartum cows has the potential to be a viable way to improve productivity and potentially longevity in commercial dairies, although further research is necessary to optimize recommendations for producers.
先前的研究表明,产后给老年奶牛(第3胎及以上)施用非甾体抗炎药(NSAID)水杨酸钠可提高305天的产奶量。然而,在这项先前的研究中,水杨酸钠是通过饮用水给奶牛服用的,这种方法与商业奶牛场目前的分组策略不太相符。本研究的目的是在商业奶牛场采用简化的治疗方案来重复这些结果,并将水杨酸钠与另一种NSAID美洛昔康进行比较。第二胎及以上的奶牛(每组n = 51头)在分娩时被交替分配到3种处理中的1种,处理持续3天。实验处理在分娩后12至36小时开始,分别为:(1)第一天1次安慰剂推注,连续3天每天灌服水杨酸钠(125克/头/天;SAL);(2)1次美洛昔康推注(675毫克/头)和3次等量水的灌服(MEL);或(3)1次安慰剂推注和3次水的灌服(CON)。在处理的第一天、处理的最后一天结束后立即以及处理的最后一天结束后7天采集血样;分析血浆中的葡萄糖、β-羟基丁酸(BHB)、游离脂肪酸、触珠蛋白和对氧磷酶。在处理后365天监测产奶量、体况评分、繁殖状况和牛群留存情况,并在混合效应模型中评估处理、胎次、产奶天数及其相互作用的影响。P<0.05时具有统计学意义。NSAID处理的奶牛全泌乳期的产奶量和蛋白质产量更高,尽管305天的脂肪产量没有受到影响。血浆葡萄糖浓度存在处理和胎次的显著交互作用;与CON和SAL相比,MEL使老年奶牛的血浆葡萄糖浓度升高。与MEL相比,处理后7天时水杨酸钠降低了血浆BHB浓度,尽管在处理后立即未检测到差异。与CON相比,SAL奶牛的触珠蛋白浓度升高。CON组奶牛比MEL组奶牛更快地被从牛群中淘汰(处理后365天时分别为42%和26%)。体况评分、血浆游离脂肪酸和对氧磷酶浓度以及怀孕时间不受处理的影响。这些结果表明,产后给奶牛施用NSAID有可能成为提高商业奶牛场生产力和潜在寿命的可行方法,尽管需要进一步研究来优化对生产者的建议。